Home > Boards > US Listed > Cannabis > Zynerba Pharmaceuticals (ZYNE)

OT;Hope evryone had a chance to watch the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dhbuzz Member Profile
 
Followed By 10
Posts 2,831
Boards Moderated 0
Alias Born 03/01/19
160x600 placeholder
Zynerba Pharma pops 4% after securing new European patent for Zygel CBD gel Seeking Alpha - 11/22/2021 8:03:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/22/2021 7:23:52 AM
Zynerba Pharmaceuticals Announces Issuance of New Patent in EU for Zygel™ GlobeNewswire Inc. - 11/22/2021 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 7:35:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 7:24:52 AM
Zynerba Pharmaceuticals EPS misses by $0.01 Seeking Alpha - 11/15/2021 7:24:29 AM
Zynerba Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Highlights GlobeNewswire Inc. - 11/15/2021 7:00:00 AM
Zynerba Pharmaceuticals Announces Presentations at Two Upcoming Scientific Conferences in October GlobeNewswire Inc. - 10/21/2021 7:00:00 AM
Zynerba Pharmaceuticals Announces Presentation of Poster at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit GlobeNewswire Inc. - 10/19/2021 4:15:00 PM
Zynerba Pharmaceuticals Announces Presentation of Poster at the 2021 American Academy of Pediatrics National Conference & Exhibition GlobeNewswire Inc. - 10/8/2021 7:30:00 AM
Zynerba Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/20/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 7:13:01 AM
Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel™ in Fragile X Syndrome GlobeNewswire Inc. - 9/13/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2021 7:11:22 AM
Zynerba Pharmaceuticals Presents Longer Term Tolerability and Efficacy Data of Zygel™ in Children and Adolescents with Autism Spectrum Disorder (ASD) at The Society for the Study of Behavioural Phenotypes (SSBP) Conference 2021 GlobeNewswire Inc. - 9/9/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/7/2021 7:11:28 AM
Zynerba Pharmaceuticals Announces Publication of Results of Phase 2 BELIEVE Open-Label Study of Zygel™ in Children and Adolescents with Developmental and Epileptic Encephalopathies (DEE) in JAMA Network Open GlobeNewswire Inc. - 9/7/2021 7:00:00 AM
Zynerba Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference GlobeNewswire Inc. - 9/2/2021 7:30:00 AM
Zynerba Pharmaceuticals Announces Oral Presentations at The Society for the Study of Behavioural Phenotypes (SSBP) Conference 2021 GlobeNewswire Inc. - 9/2/2021 7:00:00 AM
Zymergen Investor Alert - Klafter Lesser LLP, a Highly Accomplished Class Action Law Firm, Announces That a Class Action Has Been Filed Business Wire - 8/11/2021 5:30:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2021 7:32:15 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2021 7:08:05 AM
Zynerba Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights GlobeNewswire Inc. - 8/9/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2021 5:29:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2021 5:27:43 PM
dhbuzz   Sunday, 05/31/20 02:57:36 PM
Re: None
Post # of 2660 
OT;Hope evryone had a chance to watch the Dragon launch yesterday,and docking today. WOW! Congrats to Elon and NASA. WELCOME BACK TO SPACE USA!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences